Clinical evaluation of risankizumab for Crohn's disease
This article will review risankizumab, a monoclonal antibody targeting interleukin 23 (IL-23) for the treatment of moderate to severe Crohn’s disease.
Source: dovepress.com
Co Primary Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Co Primary Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Co Primary Endpoints Today - Breaking & Trending Today